Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

October 22, 2025 10:44 ET | Source: Research and Markets

T-Cell Malignancies Pipeline Research Report 2025: Market Opportunities with Over 75 Companies and 80+ Drugs, Exploring Novel Treatments Like CAR-T Therapies and Targeted Therapies

Dublin, Oct. 22, 2025 (GLOBE NEWSWIRE) -- The "T-Cell Malignancies - Pipeline Insight, 2025" has been added to ResearchAndMarkets.com's offering. The report offers in-depth analysis of over 75...
October 14, 2025 07:30 ET | Source: Aanastra Inc

Aanastra Inc Announces Presentations of Preclinical Data at Upcoming Conferences in Support of its Lead Programs for Anti-CD19 In Vivo CAR-T (AAN-14x) and In vivo Rescue of P53 Mutations in Tumors (AAN-53x)

Aanastra Inc to present preclinical data for in vivo CAR-T and p53 RNA programs leveraging its proprietary PEP-NP™ peptide delivery technology
May 22, 2025 07:37 ET | Source: Research and Markets

Peptide Cancer Drug Clinical Trials Market Insights, 2030: Multi-functional Peptides - A New Frontier in Theranostics

Dublin, May 22, 2025 (GLOBE NEWSWIRE) -- The "Peptide Cancer Drug Market Size, Dosage, Drug Price, Sales & Clinical Trials Insight 2030" has been added to ResearchAndMarkets.com's offering. ...
November 27, 2024 04:10 ET | Source: Research and Markets

Peptide Cancer Drug Market Research 2024-2030: 230 Drugs in Clinical Trials, 30 Approved Drugs, $18 Billion Opportunity, Commercially Approved Peptide Cancer By Brand Name, Company and Indication

Dublin, Nov. 27, 2024 (GLOBE NEWSWIRE) -- The "Peptide Cancer Drug Market Size, Dosage, Drug Price, Sales & Clinical Trials Insight 2030" report has been added to ResearchAndMarkets.com's...
June 18, 2024 10:17 ET | Source: Research and Markets

Comprehensive Insights of Global Cyclin-Dependent Kinase Inhibitor Pipeline

Dublin, June 18, 2024 (GLOBE NEWSWIRE) -- The "Cyclin-Dependent Kinase Inhibitor - Pipeline Insight, 2024" report has been added to ResearchAndMarkets.com's offering.The detailed report furnishes...
May 02, 2024 06:30 ET | Source: Aanastra Inc

Aanastra Inc to Showcase its Peptide-RNA Therapeutics Technology in Multiple Presentations at the American Society for Gene and Cell Therapies (ASGCT) Annual Meeting 2024

Aanastra showcases its peptide-RNA therapeutics targeting p53, KRAS and BRCA-1 driven cancers, hemophilia A and PCSK9 for hypercholestrolemia at ASGCT
April 03, 2024 06:30 ET | Source: Aanastra Inc

Aanastra Inc to Present Multiple Posters on RNA Therapeutics at the American Association for Cancer Research (AACR) Annual Meeting 2024

Aanastra to present its RNA peptide therapeutics technology at AACR conference
November 20, 2023 10:28 ET | Source: Research and Markets

Global Cyclin-Dependent Kinase Inhibitor Drug Pipeline Research Report 2023: Therapeutics Assessment by Product Type, Stage, Route of Administration, and Molecule Type

Dublin, Nov. 20, 2023 (GLOBE NEWSWIRE) -- The "Cyclin-Dependent Kinase Inhibitor - Pipeline Insight, 2023" drug pipelines has been added to ResearchAndMarkets.com's offering."Cyclin-Dependent...
September 15, 2023 10:18 ET | Source: Research and Markets

Metastatic Cancer Drug Market Thrives with Collaborative Innovations: Pfizer, Sanofi, and Merck Leading the Charge

Dublin, Sept. 15, 2023 (GLOBE NEWSWIRE) -- The "Global Metastatic Cancer Drugs Market Size, Share & Industry Trends Analysis Report By Distribution Channel, By Indication, By Therapy (Targeted...
July 06, 2023 05:23 ET | Source: Research and Markets

Global Peptide Cancer Drug Market 2023: New Technological Innovations Drive Growth

Dublin, July 06, 2023 (GLOBE NEWSWIRE) -- The "Global Peptide Cancer Drug Market, Dosage, Price, Sales and Clinical Trials Insight 2029" report has been added to ResearchAndMarkets.com's...